07 . 01 . 2014

Xeltis Appoints Nobel Prize Winner Prof. Jean-Marie Lehn To Its Advisory Board

Xeltis, a privately held medical device company dedicated to transforming standards of care in heart valve replacement and vascular surgery, has announced that Prof. Jean-Marie Lehn, Ph.D., has joined its scientific advisory board. Lehn is co-winner of the 1987 Nobel Prize in Chemistry for his work in supramolecular chemistry, the science that Xeltis used as the basis for its self-healing implant technology. He joins the company’s scientific advisory board in the midst of its first-in-human feasibility study at the prestigious Bakoulev Center for Cardiovascular Surgery in Moscow.   READ MORE…

Go back